By measuring: leptin and ghrelin levels, both within context of sex and BMI, and in conjunction with gut microbiota composition and MDD symptomology, researchers will be able to stratify the clinical population in more homogenous subgroups. This evidence concerns the gene LEP and major depressive disorder.